Issue | Pharma's Almanac

Current Issue: Q3 2016

Future Pharma Partner Models

Also In This Issue

Sustainable Strategies for Contract Development and Manufacturing Service Growth

Members of the “Who’s Who” of CMO/CDMO leadership are pursuing robust growth strategies to keep the CDMO segment energized and interesting. Acquisition has become a favorite tactic by contract pharma’s most prominent players, but there’s more than one path to sustained growth, especially for those seeking the scale, global presence and technical acumen the bio/pharmaceutical […]

Applying Advanced Protein Engineering Technologies to Biotherapeutic Development

By applying its CodeEvolver® directed evolution technology, Codexis has been improving enzymes for specific functions in challenging environments for well over a decade, using high-throughput gene synthesis, biochemical screening and advanced data analytics. Recently we have demonstrated that this technology can impact biologic drug candidate discovery and optimization. By applying the same core technology and […]

Q: What Have You Found to be the Greatest Benefit from Close Collaboration Partnership Models?

Nicholas Green, President & CEO, Therapure Biopharma Inc. A: The benefits can fall into a wide variety of categories. The more we act as a single business or partnership, the more waste or duplication of effort we can eliminate, and in so doing there is more value for both parties to share. As the teams develop […]

Function and Form: Advanced Pharma Packaging Design and Processing

As pressure mounts to get highly efficacious drug products that facilitate patient adherence through unique functionality and ease of use to market faster, pharmaceutical manufacturers are increasingly recognizing the importance of effective secondary packaging. Contract packaging firms that offer low cost, timeliness, flexibility and creativity, combined with assured high quality, can add real value by […]

Innovating Equipment: Inline Buffer Dilution Technology

Nice Insight is in conversation with Kimo Sanderson, at Asahi Kasei Bioprocess America, to discuss the company’s “technology of the decade.” Inline buffer dilution (IBD) has been recognized as a game changer and a highly optimized solution to this critical processing step. Kimo Sanderson, Vice President of Marketing and Client Services at Asahi Kasei Bioprocess […]

Pharma’s Renaissance Continues

In observing the pharma industry over the years it has yet to cease to amaze me. As it should, and not solely because the industry is a source of products that, for many, are miraculous in their life-changing abilities. My amazement stems more from how the industry accomplishes all that it does in the face […]

Fill-Finish

Harnessing CDMO Expertise for Fill-Finish and Inspection of Sterile Pharmaceuticals

Sterile pharmaceutical drug development presents unique production challenges. As biopharmaceuticals continue to grow in popularity and biosimilars become more commonplace, research and development in the area of sterile drug production will only continue to evolve. The 2016 Nice Insight CDMO Outsourcing Survey found that 66% and 50% of respondents’ businesses were engaged in the development […]

Embracing Formulation Expertise to Extend Exclusivity & Improve the Patient Experience

Offering potential exclusivity and access to larger markets, reformulation efforts can prove extremely valuable to both pharmaceutical and biopharmaceutical manufacturers. With reliable CDMO support, this value can be developed in a cost-effective manner and with minimal inconvenience, while reducing the impact of patent loss. With considerable room for growth in emerging markets, the surge in […]

Past Issues

View all Past Issues

The Next-Generation Issue

View Issue »

Issue #2 | Volume #4 | Q2 2018

The Outsourcing Issue

View Issue »

Issue #3 | Volume #6 | Q3 2020

The Advanced Therapeutics Issue

View Issue »

Issue #2 | Volume #5 | Q2 2019

The Networking Issue

View Issue »

Issue #3 | Volume #5 | Q3 2019